Comparative Assessment of Lixisenatide, Exenatide, and Liraglutide Pen Devices: A Pilot User-Based Study

BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists are a relatively recent addition to the treatment options for type 2 diabetes mellitus (T2DM) and are administered using prefilled pen devices. METHOD: In this open-label task and interview-based pilot study, 3 GLP-1 receptor agonist pen...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Diabetes Sci Technol
Hlavní autoři: Stauder, Udo, Enginee, Diplom, Elton, Hina, Penfornis, Alfred, Edelman, Steve
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2014
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4454110/
https://ncbi.nlm.nih.gov/pubmed/24876548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296813511733
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky